Palatin Technologies
PTN
#10975
Rank
โ‚ฌ8.34 M
Marketcap
4,68ย โ‚ฌ
Share price
2.54%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -โ‚ฌ5.33 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ12.88 Million. In 2025 the company made an earning of -โ‚ฌ8.62 Million, an increase over its 2024 earnings that were of -โ‚ฌ24.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ5.33 Million-38.23%
2025 -โ‚ฌ8.62 Million-64.29%
2024 -โ‚ฌ24.13 Million-16.9%
2023 -โ‚ฌ29.04 Million5.99%
2022 -โ‚ฌ27.4 Million-13.7%
2021 -โ‚ฌ31.75 Million33.25%
2020 -โ‚ฌ23.82 Million-172.11%
2019 โ‚ฌ33.03 M2352.33%
2018 โ‚ฌ1.34 M-94.13%
2017 โ‚ฌ22.95 M-154.92%
2016 -โ‚ฌ41.8 Million3.67%
2015 -โ‚ฌ40.32 Million878%
2014 -โ‚ฌ4.13 Million-72.64%
2013 -โ‚ฌ15.07 Million-33.11%
2012 -โ‚ฌ22.53 Million77.71%
2011 -โ‚ฌ12.68 Million
2003 -โ‚ฌ21.47 Million29.93%
2002 -โ‚ฌ16.52 Million36.18%
2001 -โ‚ฌ12.13 Million
1999 -โ‚ฌ10.07 Million6.04%
1998 -โ‚ฌ9.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.47 B-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.83 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.73 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚ฌ9.63 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.21 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.12 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ26.41 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ49.69 Million 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA